Listed below are conditions associated with neurocognitive disorder.

BRAIN INJURY CAUSED BY TRAUMA

• Bleeding into the brain (intracerebral hemorrhage)
• Bleeding into the space around the brain (subarachnoid hemorrhage)
• Blood clot inside the skull but outside the brain and its covering, which may cause pressure on the brain (subdural hematoma or epidural hematoma)
• Concussion

BREATHING CONDITIONS

• Low oxygen in the body (hypoxia)
• High carbon dioxide level in the body (hypercapnia)

CARDIOVASCULAR DISORDERS

• Dementia due to many strokes (multi-infarct dementia)
• Heart infections (endocarditis, myocarditis)
• Stroke
• Transient ischemic attack (TIA)

DEGENERATIVE DISORDERS

• Alzheimer disease (also called senile dementia, Alzheimer type)
• Creutzfeldt-Jakob disease
• Diffuse Lewy body disease
• Huntington disease
• Normal pressure hydrocephalus
• Parkinson disease
• Pick disease

AUTOIMMUNE DISEASES

• Multiple sclerosis
• Autoimmune encephalitis

DEMENTIA DUE TO METABOLIC CAUSES

• Kidney disease
• Liver disease
• Thyroid disease (hyperthyroidism or hypothyroidism)
• Vitamin deficiency (B1, B12, or folate)

DRUG AND ALCOHOL-RELATED CONDITIONS

• Alcohol withdrawal state
• Intoxication from drug or alcohol use
• Medicine effect, such as corticosteroids, sedative-hypnotics, antihistamines, and antidepressants
  
• Wernicke-Korsakoff syndrome, a long-term effect of deficiency of thiamine (vitamin B1)
• Withdrawal from medicines, such as sedative-hypnotics and corticosteroids

INFECTIONS

• Any sudden onset (acute) or long-term (chronic) infection
• Blood poisoning (septicemia)
• Brain infection (encephalitis)
• Meningitis (infection of the lining of the brain and spinal cord)
• Prion infections, such as mad cow disease
• Late-stage syphilis

Complications of cancer and cancer treatment with chemotherapy and radiation therapy to the brain can also lead to neurocognitive disorder.

Other conditions that may mimic neurocognitive disorder include:

• Depression
• Neurosis
• Psychosis

Symptoms can differ based on the disease. In general, neurocognitive disorder causes:

• Agitation
• Confusion
• Long-term loss of brain function (mild cognitive impairment or dementia)
• Severe, short-term loss of brain function (delirium)

Tests depend on the disorder, but may include:

• Blood tests
• Neuropsychological testing
• Electroencephalogram (EEG)
• Head CT scan
• Head MRI 
• Lumbar puncture (spinal tap)

Treatment depends on the underlying condition. Many conditions are treated mainly with rehabilitation and supportive care to help the person with activities lost due to areas where brain function is affected.

Medicines may be needed to reduce aggressive behaviors that can occur with some of the conditions.

Some disorders are short-term and reversible. But many are long-term or get worse over time.

People with neurocognitive disorder often lose the ability to interact with others or function on their own.

Contact your health care provider if:

• You have been diagnosed with neurocognitive disorder and you are uncertain about the exact disorder.
• You have symptoms of this condition.
• You have been diagnosed with neurocognitive disorder and your symptoms become worse.

Organic mental disorder (OMS); Organic brain syndrome

Beck BJ, Smith FA, Stern TA. Mental disorders due to another medical condition. In: Stern TA, Wilens TE, Fava M, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 3rd ed. Philadelphia, PA: Elsevier; 2025:chap 21.

Inouye SK. Delirium and changes in mental status. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 361.

Knopman DS. Cognitive impairment and dementia. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 371.

Merrick ST, Glesby MJ. Systemic manifestations of HIV/AIDS. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 359.

Sorg EM, Jankauskaite G, Jacobs J. Psychiatric co-morbidities and complications of cancer and cancer treatment. In: Stern TA, Wilens TE, Fava M, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 3rd ed. Philadelphia, PA: Elsevier; 2025:chap 46.

Updated by: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.